Coats’ disease in Tanzania: first case report and literature review by Rugwizangoga, B et al.
Coats’ disease in Tanzania: first case report and literature review
 
Rugwizangoga, Belson; Mwabili, Theresia; Meyer, Peter; Kitinya, James
Muhimbili National Hospital, Scanlan, Trisha; Muhimbili National Hospital, Paediatric Oncology
Muhimbili University of  Health and Allied Sciences   
Abstract
Background: 
Coats’ disease is an exudative retinal detachment with vascular telangiectasis occurring mostly in male children, the age group 
most affected by retinoblastoma. 
Objectives:
To compare the differential diagnoses of  Coats’ disease
To establish recommendation to early disease detection.
Materials and Methods:
A 3-year-old female child was referred to Muhimbili National Hospital (MNH), Tanzania, in September 2011. She had 
presented at the peripheral hospital with gradual onset of  left eye leukocoria for 1 year and pain for 2 months. B-scan showed 
a mass in the left eye. A clinical diagnosis of  retinoblastoma was made. Left eye enucleation was performed; the patient was 
referred to MNH, with the enucleated specimen.
Results: 
Brain and orbits scan revealed no residual tumour.  The globe measured 2x1.8 cm, the optic nerve stump measured 3 mm. A 
whitish mass filled the vitreous, with complete retinal detachment. Microscopy showed retinal gliosis, detachment with sub 
retinal PAS positive exudates, vacuolation and cholesterol clefts. Foreign body giant cells were present; telangiectatic thin-
walled blood vessels were identified. Clinico-pathological findings were of  stage 4 Coats’ disease.
Conclusion:
Coats’ disease is an important differential diagnosis of  retinoblastoma. Delay to detect Coats’ disease leads to vision loss 
which necessitates eye enucleation as was in this child.
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Background
Coats’ disease is an exudative retinopathy associated 
with retinal detachment and vascular telangiectatic foci. 
This disease was first described in 1908 by Georges 
Coats (1). It is more common in young male children 
(2; 3).  It is associated with somatic mutation in NDP 
gene located on chromosome Xp11.2 (4). 
Coats’ disease is characterized by vascular telangiectasis 
in the peripheral area of  retina, which causes leakage of  
exudate in retinal outer layers and sub retinal space, 
leading to the retinal detachment. The presence of  the 
unilateral leukocoria and the growth of  the lesion in 
sub retinal layers mimic an exophytic retinoblastoma; 
this makes Coats’ disease an important differential 
diagnosis to the unilateral retinoblastoma (2; 3). There 
is a scarcity of  reports on Coats’ disease in Africa and 
no prior cases have been in Tanzania. We herein report 
a case of  Coats’ disease in a 3-year old girl, followed by 
a brief  literature review.  
Case report
Medical history
We report a case of  a 3-year old female child. She 
presented with left eye leukocoria for 1 year, pain 
associated with scratching for 2 months, left eye 
proptosis and redness for 1 month. The symptoms 
were of  gradual onset, progressive, without aggravating 
factors. No eye discharge or bleeding was associated. The 
familial and personal medical history was unremarkable; 
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the stature, body mass and mental growth were normal. 
The child was brought to the nearby District Hospital 
which referred her to a Rehabilitation Centre without a 
firm diagnosis being made.
Clinical and Para clinical findings
The examination performed at the Rehabilitation 
Centre revealed left leukocoria and vision loss. B-scan 
ultrasound showed left eye posterior mass. The right 
eye and other systems were normal. 
Patient management
The clinical impression was left eye retinoblastoma. 
Left eyeball enucleation was performed. The patient 
was referred to Muhimbili National Hospital (MNH), 
with the eyeball specimen in fixative, for diagnosis and 
management.
The patient was received at MNH 3 days after 
enucleation; the full blood picture showed mild 
microcytic and hypochromic anaemia with anisocytosis. 
The comprehensive chemistry panel (CCP) was 
unremarkable. The enzyme-linked immunosorbent 
assay (ELISA) test was negative for the human 
immunodeficiency virus (HIV). The computer 
tomography scan of  the brain showed a normal brain 
without evident metastatic lesion; ventricles and sulci 
were normal. Bone marrow aspirate (BMA) showed 
no evidence of  malignant infiltrate. The peripheral 
blood film showed was unremarkable. The patient was 
admitted for post-operation management, waiting for 
the histology diagnosis. 
Gross examination of  specimen
The eyeball specimen was received fixed in 10% buffered 
formalin. Grossly, the eyeball had no lateralizing signs. 
A stump of  the optic nerve was attached, measuring 
3mm of  length. The globe itself  measured 2x1.8 cm. 
Cut sections of  the globe showed a soft white mass 
filling the vitreous; the mass involved the entire retina 
(Figure 1A). 
Figure1. Morphological findings in our reported case 
of  Coats’ disease. A: Gross cut section of  the eyeball, 
showing a whitish mass filling the vitreous. 
The cornea was misty but the lens was normal. No 
obvious optic nerve involvement was noted. As the 
microscopy of  the primary slides showed no evidence 
of  retinoblastoma, the whole eyeball was subsequently 
sectioned and processed, to exclude the possibility of  
retinoblastoma.
Microscopy 
The sections from the eyeball, stained with Haematoxylin 
and Eosin (H&E) showed flocculation of  the cornea 
without inflammation, consistent with oedema. The 
iris and lens were normal. Both anterior and posterior 
chambers of  the aqueous humour were empty and 
normal. Gliosis at the junction of  the iris and traction 
membrane was evident.
There was total retinal detachment with intra- and sub-
retinal exudate (Figure 1B). 
B: Eyeball whole mount showed retinal detachment 
with sub retinal exudates, Haematoxylin and Eosin 
(H&E) stain.
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The whole retina showed thickening, serous vacuolation 
with cholesterol clefts (Figure 1C) and telangiectatic 
blood vessels on H&E sections and highlighted by 
CD31 immunoperoxidase staining (not shown). Macular 
retinal ganglion cell axonal count was not performed 
because the macula was involved by the exudative retinal 
detachment. 
C: Retinal serous vacuolation with cholesterol clefts 
(H&E, x 100).
The optic nerve microscopically appeared mildly 
atrophic; optic nerve axon count was not performed. 
The exudate was Periodic Acid Schiff  (PAS) positive 
(Figure 1D). A consultation of  an Ophthalmic 
Pathologist at University of  Basel, Switzerland through 
iPath confirmed the diagnosis of  Coats’ disease, stage 
4.
D: Sub retinal exudate and retinal vacuolated foci were 
PAS positive (PAS, X 400). 
Discussion and literature review
Coats’ disease is a rare non-hereditary ocular disease, 
with no systemic manifestation. It was first described by 
George Coats in 1908 (1). It is more common in children 
than in adults, and has a clear male predominance (2; 3; 
4; 5). A prospective population-based study of  Coats’ 
disease in the United Kingdom collected 55 cases during 
2008; all the cases were unilateral and 41% presented 
with Coats’ disease stage 2A at diagnosis (6). African 
data are scarce; a study done in 2011 on incidence and 
distribution of  retinoblastoma in Kenya for the period 
2006-2007, revealed two cases of  Coats’ disease that 
were misdiagnosed as retinoblastoma, but their stages 
were not specified (7).
Genetics
About 100 NDP mutations are recognized; these 
mutations include the germ-line mutation in Xp11.3 
causing Norrie disease (8). Coats’ disease is associated 
with somatic mutation in Norrie Disease Protein (NDP) 
gene located on chromosome Xp11.2, leading to a 
deficiency of  norrin (4). Norrin is a protein product 
of  the NDP gene, which is critical for normal retinal 
vasculogenesis (8). A somatic NDP mutation causing 
Coats’ disease is thought to occur within cells of  
neuroectodermal origin at a stage of  retina development; 
the high male: female ratio is thought to result from 
partial escape of  X-inactivation in females (4).
Pathogenesis and histology
Coats’ disease presents with vascular telangiectasis in 
the peripheral area of  retina; this causes the leakage of  
an exudate in retinal outer layers and sub retinal space, 
which leads to the retinal detachment; the exudate 
stains positive with periodic acid Schiff  (PAS), and is 
rich in lipids and foamy macrophages; cholesterol clefts 
are seen in the sub retinal spaces (3). Vascular growth 
factor (VEGF) plays a central role in the genesis of  
telangectasia and increased vascular permeability, as 
well as in sub retinal space infiltration by macrophages 
(9). In fact, there are significant correlations between 
VEGF immunoreactivity in retinal endothelial cells and 
the presence of  retinal vascular abnormalities, VEGF 
Immunoreactivity in the detached retina and dilated 
vessels, and VEGF immunoreactivity in macrophages 
infiltrating the sub retinal proliferative tissue (9). 
Clinical findings and differential diagnoses
Clinically, most cases present with a unilateral progressive 
loss of  vision, strabismus or leukocoria; this makes 
unilateral retinoblastoma an important differential 
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diagnosis since the two conditions appear in the 
same age group, with clinical features that overlap (3). 
Currently, a handheld portable spectral-domain optical 
coherence tomography (OCT) system is being used as as 
a novel and critical intraoperative tool in differentiating 
Coats disease from diffuse retinoblastoma and other 
mimicking conditions; it also helps to monitor the 
treatment  response in Coats disease (10).
Coats disease affects mostly young children who cannot 
indicate their symptoms; it is therefore usually detected 
in advanced stages with fovea involvement. Awareness 
of  the differential diagnosis of  leucokoria by the 
ophthalmologist during ophthalmoscopy is crucial 
in identifying conditions like Coats’ disease, toxocara 
endophthalmitis, persistent hyperplastic primary vitreous (PHPV) and Norrie disease before eye enucleation for 
retinoblastoma.
PHPV and toxocara endophthalmitis are other differential diagnoses of  Coats’ disease which grossly mimic 
endophytic retinoblastoma and microscopically, they show vitreous fibrosis and vascularisation. Coats’ disease, on 
the other hand, mimics exophytic retinoblastoma (3). The other differential diagnosis of  Coats’ disease is Norrie 
disease (8). 
Table 1 Differences between Coats disease and Norrie disease. 
Features Coats’ Disease Norrie Disease 
Mutation NDP (Xp11.2) Somatic 
Mutation 
NDP (Xp11.3) Germ-line 
Mutation 
Age of  onset of  
symptoms/signs 
Childhood, sometimes adult 
onset of  blindness 
Early infancy, neonatal 
or antenatal (in utero 
ultrasonography) clinical 
manifestation 
Sex ratio Male: Female > 3:1. (2; 6) Exclusively Males 
Familial characteristics No familial predilection Familial predilection 
Signs and symptoms Unilateral (80%) leukocoria 
and/or strabismus and loss of  
vision
Bilateral leukocoria and/or 
strabismus and loss of  vision
Peripheral venous insufficiency 
Mental retardation
Sensorineural deafness. 
Complications Glaucoma, cataract Glaucoma, cataract 
Gross findings Retrolental whitish mass Retrolental yellowish mass 
Histology Vascular telangiectasis 
PAS-positive exudates 







Gliosis, cysts and haemorrhage 
Norrie disease is an X-linked recessive disorder 
characterized by congenital bilateral blindness due to 
degenerative and proliferative changes of  the retina 
and optic nerve in males; it is caused by a germ-line 
mutation in Norrie Disease Protein (NDP) gene encoding 
for norrin, located on chromosome Xp11.3; the norrin 
protein plays a role in normal retinal angiogenesis, and 
some reports suggest its role in non-ocular angiogenesis 
(8). Children affected by Norrie disease present with 
blindness at birth or early infancy (8), because it results 
from germ-line NDP mutation, in contrast to Coats 
disease which results from a somatic NDP mutation. 
Table 1 summarizes the differences between Coats’ 
disease and Norrie disease.
Staging and management of  Coats’ disease
Coats’ disease progresses gradually and affects central 
vision. When Coats’ disease is detected early, some level 
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of  vision can typically be restored. If  not detected until its late stages, complete loss of  vision can occur and 
enucleation may be necessary.
Five stages of  Coats’ disease are recognized (11), but published data show differences in staging criteria, as 
presented in table 2.
Table 2 Staging criteria and management of  Coats’ disease
Staging Criteria Management 
option of  choice
Stage according to different 
authors
Shields et al. (11), Brinton et al. 
(12), Kase et al. (9)
Kase et al. (9) Shields et al. 
(11)






injection into the 
vitreous
Stage 1 Stage 1




Telangiectasia and foveal exudation Stage 2B




Foveal subtotal exudative retinal 
detachment
3A (ii)
Total exudative retinal detachment Surgical retinal 
reattachment; 
Anti–VEGF agent 




Total retinal exudative detachment 
and glaucoma
Enucleation Stage 4
Advanced end-stage disease, with 
cataract or phthisis bulbi
Observation / 
enucleation
Stage 5 Stage 5
The staging system according to Shields et al. seems to 
be the most accepted (6). Other conservative therapeutic 
methods include intravitreal injections of  steroids or 
vascular endothelial growth factor (VEGF) inhibitors 
(6; 9; 12).
Tanzania data
No other case of  Coats disease had been reported 
in Tanzania. The review of  all eye enucleation cases 
received at MNH from 2009 to 2011 revealed no 
other case of  Coats disease. Table 3 shows the disease 
distribution in eyes enucleated at MNH department of  
Paediatrics from January 2009 to December 2011. 
Table 3 Distribution of  eye enucleation paediatric cases at MNH, 2009-2011
Year Eye enucleation 
in children (< 15 
years of  age) 




2009 28 24 0 2 2
2010 29 26 0 1 2
2011 60 53 1 2 4
Total 117 103 1 5 8
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Concerning our case, the disease was at early stage 4 
characterized by total retinal detachment and signs of  
early glaucoma, that is, pain, proptosis, retinal gliosis and 
optic nerve mild atrophy. The optic disc cupping could 
not be assesses. The clinical presentation was strongly 
suggestive of  unilateral retinoblastoma. The telangiectatic 
vessels depicted on B-scan ultrasonography may be also 
found in some cases of  intraocular retinoblastoma (3). 
Radiologic examinations may reveal calcifications in 
either retinoblastoma or Coats disease. Enucleation was 
justified by the total retinal detachment and signs of  
glaucoma (11; 12). 
Conclusion
Coat’s disease is a challenging differential diagnosis 
of  unilateral retinoblastoma. Its clinical recognition at 
early stages leads to the salvage of  the vision of  the 
involved eye. Clinicians, radiologists and pathologists 
should keep in mind the possibility of  this disease when 
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